About 500 Mg Abiraterone Acetate Tablets IP
Experience first-string hormonal therapy with 500 Mg Abiraterone Acetate Tablets IP, designed to deliver majestic efficacy in treating prostate cancer. Each lavishly engineered blister pack or bottle contains 60 white to off-white, film-coated, easy-to-swallow tablets, ensuring consistent oral administration. Approved by CDSCO, India, this prescription-only medication offers competitive pricing and significant savings, making it highly recommended for eligible patients. With a robust shelf life of 24 months and optimal storage requirements, these tablets stand out for distributors, exporters, suppliers, and traders across India.
Extensive Application in Prostate Cancer Treatment
500 Mg Abiraterone Acetate Tablets IP is primarily used as part of an advanced hormonal therapy regimen for prostate cancer. Applied in oncology clinics and specialized hospitals, its high efficacy and oral administration method make it a convenient choice for patients. The film-coated design offers additional comfort during ingestion, while the majestic strength of 500 mg ensures a robust therapeutic response for eligible male patients.
Reliable Supply and Order Fulfillment
With strong supply ability and efficient packing & dispatch processes, 500 Mg Abiraterone Acetate Tablets IP maintains consistent market value for distributors and exporters in India. Orders are promptly completed through major FOB ports with flexible payment terms, optimizing the order completion experience. The robust shelf life and secure packaging further ensure product integrity during transit and delivery.
FAQ's of 500 Mg Abiraterone Acetate Tablets IP:
Q: How should 500 Mg Abiraterone Acetate Tablets IP be taken?
A: This medication should be taken by mouth on an empty stomach, as directed by your healthcare provider. Follow your doctor's dosage instructions strictly for optimal efficacy.
Q: What are the main benefits of using Abiraterone Acetate Tablets IP 500 mg for prostate cancer?
A: The main benefits include its high efficacy in hormonal therapy for prostate cancer, oral administration for patient convenience, and film-coated tablets for easy swallowing.
Q: When is it recommended to use Abiraterone Acetate Tablets IP?
A: It is prescribed for men with prostate cancer as determined by a qualified healthcare provider, based on individual medical assessment and indication.
Q: Where is this product approved and available?
A: 500 Mg Abiraterone Acetate Tablets IP is approved by the CDSCO in India and is distributed, exported, and supplied throughout the country.
Q: What are the usage restrictions and contraindications for this medication?
A: This medicine must not be used by women or children, and it is contraindicated in pregnancy and in individuals with known hypersensitivity to abiraterone acetate.
Q: How does the order and supply process ensure product quality?
A: Packing & dispatch procedures maintain product integrity, while all tablets are packed securely to protect from moisture and light, ensuring patients receive high-quality medication.